Ebola Virus Glycoprotein (EBOV GP) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-Ebola Virus Glycoprotein (EBOV GP) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Ebola Virus Glycoprotein (EBOV GP) |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | n/a |
| Isotype | n/a |
| Format | antigen affinity purified |
| Size | 50 µl, 100 µl, |
| Concentration | 1 mg/ml |
| Applications | ELISA |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Ebola Virus Glycoprotein (EBOV GP) antibody (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15) is a Rabbit polyclonal antibody for the detection of Ebola Virus Glycoprotein (EBOV GP). The fourth gene of the EBOV genome encodes a 16-kDa envelope-attached glycoprotein (GP) and a 11 kDa secreted glycoprotein (sGP). Both GP and sGP have an identical 295-residue N-terminus, however, they have different C-terminal sequences. Recently, great attention has been paid to GP for vaccines design and entry inhibitors isolation. GP is a class I fusion protein which assembles as trimers on viral surface and plays an important role in virus entry and attachment. Mature GP is a disulfide-linked heterodimer formed by two subunits, GP1 and GP2, which are generated from the proteolytical process of GP precursor (pre-GP) by cellular furin during virus assembly . The GP1 subunit contains a mucin domain and a receptor-binding domain (RBD); the GP2 subunit has a fusion peptide, a helical heptad-repeat (HR) region, a transmembrane (TM) domain, and a 4-residue cytoplasmic tail. The RBD of GP1 mediates the interaction of EBOV with cellular receptor (e.g. DC-SIGN/LSIGN, TIM-1, hMGL, NPC1, ?-integrins, folate receptor-?, and Tyro3 family receptors), of which TIM1 and NPC1 are essential for EBOV entry; the mucin domain having N- and O-linked glycans enhances the viral attachment to cellular hMGL, and participates in shielding key neutralization epitopes, which helps the virus evades immune elimination. There are large conformation changes of GP2 during membrane fusion, which enhance the insertion of fusion loop into cellular membrane and facilitate the release of viral nucleocapsid core to cytoplasm. |
| Immunogen | Recombinant EBOV (subtype Zaire, strain H.sapiens-wt/GIN/2014/Kissidougou-C15) Glycoprotein / GP Protein |
| Other Names | EBOV GP, Ebola Virus Glycoprotein, Zaire ebolavirus Glycoprotein, Ebola Virus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15), Zaire ebolavirus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15), EBOV GP, EBOV GP, EBOV GP , EBOV GP , Ebola Virus Glycoprotein, Ebola Virus Glycoprotein, Ebola Virus Glycoprotein , Ebola Virus Glycoprotein , Zaire ebolavirus Glycoprotein, Zaire ebolavirus Glycoprotein, Zaire ebolavirus Glycoprotein , Zaire ebolavirus Glycoprotein , Ebola Virus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15), Ebola Virus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15), Ebola Virus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15) , Ebola Virus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15) , Zaire ebolavirus Glycoprotein (Subtype Zaire, Strain H. sapiens-WT/GIN/2014/Kissidougou-C15), Zaire ebolavirus Glycopr |
| Gene, Accession # | n/a |
| Catalog # | abx201307 |
| Price | please inquire |
| Order / More Info | Ebola Virus Glycoprotein (EBOV GP) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies